Research Article
A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer
Table 1
Baseline characteristics of the training and the validation cohort.
| | Variables | Training cohort () | Validation cohort () | value |
| | Age (y) | 69 (63, 75) | 68 (63, 74) | 0.462 | | BMI (kg/m2) | 23.66 (21.70, 25.66) | 24.11 (21.63, 25.95) | 0.239 | | AISI | 230.77 (154.43, 367.47) | 245.91 (145.79, 355.19) | 0.851 | | SII | 509.16 (362.76, 721.68) | 508.46 (368.64, 752.96) | 0.764 | | NLR | 2.46 (1.90, 3.30) | 2.42 (1.94, 3.52) | 0.556 | | PLR | 132.24 (105.20, 167.40) | 131.03 (101.72, 174.51) | 0.645 | | tPSA (ng/ml) | 11.23 (6.40, 25.10) | 10.99 (7.18, 23.85) | 0.294 | | fPSA (ng/ml) | 1.42 (0.85, 3.40) | 1.62 (0.81, 3.19) | 0.763 | | f/tPSA | 0.13 (0.08, 0.19) | 0.13 (0.08, 0.20) | 0.653 | | PV (ml) | 41.93 (28.97, 60.88) | 43.78 (30.21, 64.05) | 0.241 | | HBP | | | 0.031 | | No | 493 (57.8%) | 187 (51.1%) | | | Yes | 360 (42.2%) | 179 (48.9%) | | | DM | | | 0.920 | | No | 773 (90.6%) | 331 (90.4%) | | | Yes | 80 (9.4%) | 35 (9.6%) | | | PIRADS score | | | 0.681 | | 1 | 40 (4.7%) | 18 (4.9%) | | | 2 | 157 (18.4%) | 72 (19.7%) | | | 3 | 189 (22.2%) | 84 (23.0%) | | | 4 | 260 (30.5%) | 96 (26.2%) | | | 5 | 207 (24.3%) | 96 (26.2%) | |
|
|
